Don't get left behind! The modernized ClinicalTrials.gov is coming. Check it out now.
Say goodbye to ClinicalTrials.gov!
The new site is coming soon - go to the modernized ClinicalTrials.gov
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Better Effectiveness After Transition - Heart Failure (BEAT-HF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01360203
Recruitment Status : Completed
First Posted : May 25, 2011
Last Update Posted : May 11, 2016
Sponsor:
Collaborators:
Cedars-Sinai Medical Center
University of California, Davis
University of California, Irvine
University of California, San Diego
University of California, San Francisco
Information provided by (Responsible Party):
Michael Ong, University of California, Los Angeles

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to compare the effect of implementing wireless remote monitoring combined with structured telephone monitoring, versus current care, on variation in rehospitalization among older patients hospitalized with heart failure at six medical centers.

Condition or disease Intervention/treatment Phase
Heart Failure Other: Structured Telephone / Remote Outpatient Monitoring Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 1437 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Variations in Care: Comparing Heart Failure Care Transition Intervention Effects
Study Start Date : October 2011
Actual Primary Completion Date : March 2014
Actual Study Completion Date : March 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
No Intervention: Current Care
Patients will receive the current care provided to heart failure patients at each of the study sites
Experimental: Care Transition Intervention
Care transition intervention beginning prior to discharge and through six months post-discharge.
 Other: Structured Telephone / Remote Outpatient Monitoring
During their hospitalization, patients will receive education on their condition and will be taught to use a wireless remote monitoring device that they will use from home on a daily basis for six months following hospital discharge. Patients will receive structured telephone phone calls from a centralized call center nurse at least once a week for the first month post-discharge, and monthly for the remainder of the six month study period. Patients may receive additional calls depending upon the information gathered during the scheduled call center phone calls and/or their health status as ascertained by the data (weight, heart rate, blood pressure, answers to general health and heart failure-related questions) transmitted daily by the wireless remote monitoring device.
Other Names:
  • Care Transition Intervention
  • Care Transitions Intervention
  • Structured Telephone Monitoring
  • Remote Monitoring


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. 180 day rehospitalization rate [ Time Frame: at 180 days post-discharge ]
    Patient self-report in response to telephone survey, combined with administrative claims data of rehospitalization for any cause


Secondary Outcome Measures :
  1. 7 day mortality rate [ Time Frame: within 7 days post-discharge ]
    Mortality during the study period. Next of kin will be contacted in the event the patient has expired to verify death and date of death.

  2. Change in quality of Life [ Time Frame: as an inpatient, within 7 days post-discharge, and at 30 and 180 days post-discharge ]
    Quality of life scores will be measured using standardized questionnaires, and data captured during enrollment will be compared with data captured during three post-discharge phone calls

  3. 30 day mortality rate [ Time Frame: at 30 days post-discharge ]
    Mortality during the study period. Next of kin will be contacted in the event the patient has expired to verify death and date of death.

  4. 180 day mortality rate [ Time Frame: at 180 days post-discharge ]
    Mortality during the study period. Next of kin will be contacted in the event the patient has expired to verify death and date of death.

  5. 30 day rehospitalization rate [ Time Frame: at 30 days post-discharge ]
    Patient self-report in response to telephone survey, combined with administrative claims data of rehospitalization for any cause

  6. 7 day rehospitalization rate [ Time Frame: within 7 days post-discharge ]
    Patient self-report in response to telephone survey, combined with administrative claims data of rehospitalization for any cause


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   50 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients hospitalized at any of the six medical centers who are being actively treated for heart failure.

Exclusion Criteria:

  • patients who have previously received a transplant, are being evaluated for a transplant, or who are on the wait list for a transplant,
  • patients who are enrolled or enrolling in hospice, or are expected to expire shortly after discharge,
  • patients with dementia,
  • patients who are admitted from a skilled nursing facility (SNF), or who we anticipate will be discharged to a long term stay in a SNF,
  • patients who do not have a working land line phone or reliable cell service,
  • patients on chronic dialysis,
  • patients who cannot identify a usual source of care (free clinic is acceptable) and who will not be assigned a provider upon discharge,
  • patients with the following cardiovascular conditions: patients with valvular disorders requiring surgical intervention (except for those with incidental valvular disease, who will be included), acute myocardial infarction (except for those with demand ischemia, who will be included), percutaneous coronary intervention
  • patients expected to enroll in hospice or expire after discharge,
  • patients who are unable to use the intervention equipment (e.g., unable to stand on the weight scale), or who are otherwise unable to comply with the intervention
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01360203


Locations
Layout table for location information
United States, California
University of California, Davis
Davis, California, United States, 95616
University of California, Irvine
Irvine, California, United States, 92697
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048
University of California, Los Angeles
Los Angeles, California, United States, 90095
University of California, San Diego
San Diego, California, United States, 92093
University of California, San Francisco
San Francisco, California, United States, 94143
Sponsors and Collaborators
University of California, Los Angeles
Cedars-Sinai Medical Center
University of California, Davis
University of California, Irvine
University of California, San Diego
University of California, San Francisco
Investigators
Layout table for investigator information
Principal Investigator: Michael K Ong, MD, PhD University of California, Los Angeles
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Michael Ong, Associate Professor, University of California, Los Angeles
ClinicalTrials.gov Identifier: NCT01360203    
Other Study ID Numbers: R01HS019311 ( U.S. AHRQ Grant/Contract )
First Posted: May 25, 2011    Key Record Dates
Last Update Posted: May 11, 2016
Last Verified: May 2014
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Diseases
Cardiovascular Diseases